SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 374 filers reported holding SHOCKWAVE MED INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,557 | -29.8% | 716 | +0.6% | 0.00% | – |
| Q2 2023 | $203,211 | -77.9% | 712 | -83.2% | 0.00% | -100.0% |
| Q1 2023 | $921,094 | +9.2% | 4,248 | +3.5% | 0.00% | +100.0% |
| Q4 2022 | $843,823 | -16.3% | 4,104 | +13.2% | 0.00% | -50.0% |
| Q3 2022 | $1,008,000 | -39.8% | 3,627 | -58.6% | 0.00% | -33.3% |
| Q2 2022 | $1,675,000 | +23.8% | 8,764 | +34.3% | 0.00% | +50.0% |
| Q1 2022 | $1,353,000 | +434.8% | 6,526 | +359.6% | 0.00% | – |
| Q4 2021 | $253,000 | -22.9% | 1,420 | -11.2% | 0.00% | -100.0% |
| Q3 2021 | $328,000 | +3.8% | 1,599 | -4.1% | 0.00% | 0.0% |
| Q2 2021 | $316,000 | +60.4% | 1,667 | +10.1% | 0.00% | – |
| Q1 2021 | $197,000 | +39.7% | 1,514 | +11.7% | 0.00% | – |
| Q4 2020 | $141,000 | +176.5% | 1,356 | +103.6% | 0.00% | – |
| Q3 2020 | $51,000 | +96.2% | 666 | +24.5% | 0.00% | – |
| Q2 2020 | $26,000 | -39.5% | 535 | -58.4% | 0.00% | – |
| Q1 2020 | $43,000 | – | 1,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |